152 related articles for article (PubMed ID: 15050639)
1. Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity.
Hart ME; Chamberlin AR; Walkom C; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2004 Apr; 14(8):1969-73. PubMed ID: 15050639
[TBL] [Abstract][Full Text] [Related]
2. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
[TBL] [Abstract][Full Text] [Related]
3. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines.
McCluskey A; Ackland SP; Bowyer MC; Baldwin ML; Garner J; Walkom CC; Sakoff JA
Bioorg Chem; 2003 Feb; 31(1):68-79. PubMed ID: 12697169
[TBL] [Abstract][Full Text] [Related]
4. Norcantharidin analogues: synthesis, anticancer activity and protein phosphatase 1 and 2A inhibition.
Hill TA; Stewart SG; Gordon CP; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
ChemMedChem; 2008 Dec; 3(12):1878-92. PubMed ID: 19025735
[TBL] [Abstract][Full Text] [Related]
5. Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.
McCluskey A; Walkom C; Bowyer MC; Ackland SP; Gardiner E; Sakoff JA
Bioorg Med Chem Lett; 2001 Nov; 11(22):2941-6. PubMed ID: 11677131
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity.
Stewart SG; Hill TA; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem; 2007 Dec; 15(23):7301-10. PubMed ID: 17870547
[TBL] [Abstract][Full Text] [Related]
7. Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation.
Hill TA; Stewart SG; Ackland SP; Gilbert J; Sauer B; Sakoff JA; McCluskey A
Bioorg Med Chem; 2007 Sep; 15(18):6126-34. PubMed ID: 17606377
[TBL] [Abstract][Full Text] [Related]
8. Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity.
McCluskey A; Bowyer MC; Collins E; Sim ATR ; Sakoff JA; Baldwin ML
Bioorg Med Chem Lett; 2000 Aug; 10(15):1687-90. PubMed ID: 10937725
[TBL] [Abstract][Full Text] [Related]
9. Norcantharimide analogues possessing terminal phosphate esters and their anti-cancer activity.
Robertson MJ; Gordon CP; Gilbert J; McCluskey A; Sakoff JA
Bioorg Med Chem; 2011 Sep; 19(18):5734-41. PubMed ID: 21855357
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.
Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A
Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Cytotoxicity of Octahydroepoxyisoindole-7-carboxylic Acids and Norcantharidin-Amide Hybrids as Norcantharidin Analogues.
Hizartzidis L; Gilbert J; Gordon CP; Sakoff JA; McCluskey A
ChemMedChem; 2019 Jun; 14(12):1152-1161. PubMed ID: 30938091
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin analogues: a patent review (2006 - 2010).
Deng L; Tang S
Expert Opin Ther Pat; 2011 Nov; 21(11):1743-53. PubMed ID: 22017412
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative assay of norcantharidin derivatives in cancer cells.
Tu GG; Zhan JF; Lv QL; Wang JQ; Kuang BH; Li SH
Med Chem; 2014 Jun; 10(4):376-81. PubMed ID: 23909288
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
McCluskey A; Ackland SP; Gardiner E; Walkom CC; Sakoff JA
Anticancer Drug Des; 2001 Dec; 16(6):291-303. PubMed ID: 12375882
[TBL] [Abstract][Full Text] [Related]
15. Potent and selective Aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition.
Fancelli D; Berta D; Bindi S; Cameron A; Cappella P; Carpinelli P; Catana C; Forte B; Giordano P; Giorgini ML; Mantegani S; Marsiglio A; Meroni M; Moll J; Pittalà V; Roletto F; Severino D; Soncini C; Storici P; Tonani R; Varasi M; Vulpetti A; Vianello P
J Med Chem; 2005 Apr; 48(8):3080-4. PubMed ID: 15828847
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity of a salicylihalamide A analogue.
Tang S; Erickson KL
J Nat Prod; 2008 May; 71(5):898-901. PubMed ID: 18407694
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis and anticancer activity of norcantharidin-galactose derivatives].
Fan F; Sun XF
Yao Xue Xue Bao; 2008 Feb; 43(2):157-61. PubMed ID: 18507342
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of a series of norcantharidin analogues.
Tarleton M; Gilbert J; Sakoff JA; McCluskey A
Eur J Med Chem; 2012 Aug; 54():573-81. PubMed ID: 22796041
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
